Evidence map›Paper›PMID 38666815›Full record

ArticleBiology2024

Unified Convolutional Sparse Transformer for Disease Diagnosis, Monitoring, Drug Development, and Therapeutic Effect Prediction from EEG Raw Data.

Zhengda He, Linjie Chen, Jiaying Xu, Hao Lv, Rui-Ning Zhou, Jianhua Hu, Yadong Chen, Yang Gao

Open access · goldAbstract read
In one paragraph

Article in Biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Zhengda HeThe Department of Computer Science and Technology, Nanjing University, Nanjing 210023, China.
Linjie ChenLaboratory of Molecular Design and Drug Discovery, China Pharmaceutical University, Nanjing 211198, China.
Jiaying XuLaboratory of Molecular Design and Drug Discovery, China Pharmaceutical University, Nanjing 211198, China.
Hao LvLaboratory of Molecular Design and Drug Discovery, China Pharmaceutical University, Nanjing 211198, China.
Rui-Ning ZhouLaboratory of Molecular Design and Drug Discovery, China Pharmaceutical University, Nanjing 211198, China.
Jianhua HuLaboratory of Molecular Design and Drug Discovery, China Pharmaceutical University, Nanjing 211198, China.
Yadong ChenLaboratory of Molecular Design and Drug Discovery, China Pharmaceutical University, Nanjing 211198, China.
Yang GaoThe Department of Computer Science and Technology, Nanjing University, Nanjing 210023, China.
China Pharmaceutical University · CNNanjing University of Science and Technology · CN

Funding

National Natural Science Foundation of China 81973182
6 · The paper itself

Abstract

Electroencephalogram (EEG) analysis plays an indispensable role across contemporary medical applications, which encompasses diagnosis, monitoring, drug discovery, and therapeutic assessment. This work puts forth an end-to-end deep learning framework that is uniquely tailored for versatile EEG analysis tasks by directly operating on raw waveform inputs. It aims to address the challenges of manual feature engineering and the neglect of spatial interrelationships in existing methodologies. Specifically, a spatial channel attention module is introduced to emphasize the critical inter-channel dependencies in EEG signals through channel statistics aggregation and multi-layer perceptron operations. Furthermore, a sparse transformer encoder is used to leverage selective sparse attention in order to efficiently process long EEG sequences while reducing computational complexity. Distilling convolutional layers further concatenates the temporal features and retains only the salient patterns. As it was rigorously evaluated on key EEG datasets, our model consistently accomplished a superior performance over the current approaches in detection and classification assignments. By accounting for both spatial and temporal relationships in an end-to-end paradigm, this work facilitates a versatile, automated EEG understanding across diseases, subjects, and objectives through a singular yet customizable architecture. Extensive empirical validation and further architectural refinement may promote broader clinical adoption prospects.

Indexed as

disease diagnosisEEG analysispsychiatric drug discoverysparse transformer

Identifiers

PMID38666815
PMCPMC11048286
OpenAlexW4393086304

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.